参考文献/References:
[1]刘洁,伍严安,林妙春,等.急性带状疱疹患者Treg和IL-35水平与带状疱疹后遗神经痛的相关性分析[J].检验医学与临床,2021,18(5):589-592,599.[2]魏冉,卢懿,彭丽,等.带状疱疹患者血清CX3CR1、CCR2表达与带状疱疹后遗神经痛的相关性[J].疑难病杂志,2022,21(12):1283-1287,1292.[3]Malik A,Jang FF,Moosa M,et al.Frequency of Postherpetic Neuralgia In Herpes Zoster Patients[J].Pakistan Journal of Medical and Health Sciences,2021,15(6):1305-1308.[4]王珊珊,刘勇.早期疼痛和心理因素变化与带状疱疹后神经痛风险的相关性[J].蚌埠医学院学报,2021,46(12):1673-1676.[5]李玉秋,王琛,韦兰,等.带状疱疹急性期患者血清前炎性细胞因子、免疫球蛋白和T淋巴细胞亚群水平与后遗神经痛的相关性分析[J].河北医药,2020,42(6):805-809.[6]于生元,万有,万琪等.带状疱疹后神经痛诊疗中国专家共识[J].中国疼痛医学杂志,2016,22(3):161-167.[7]李星,张保朝,赵伟,等.急性期老年带状疱疹患者血清白细胞介素-1在预测发生后遗神经痛的临床效能[J].中国中西医结合皮肤性病学杂志,2020,19(5):415-418.[8]Tang Y,Ren C,Wang M,et al.Altered gray matter volume and functional connectivity in patients with herpes zoster and postherpetic neuralgia[J].Brain Res,2021,1769:147608.[9]乔子梅,薛瑶.带状疱疹病毒院内感染患者神经痛临床诊疗与病原菌分布及危险因素分析[J].山西医药杂志,2019,48(22):2780-2783.[10]Forstenpointner J,Rice ASC,Finnerup NB,et al.Up-date on Clinical Management of Postherpetic Neuralgia and Mechanism-Based Treatment: New Options in Therapy[J].J Infect Dis,2018,218(suppl_2):S120-S126.[11]翁讯,张璃.带状疱疹后遗神经痛的影响因素及其对策分析[J].中国医院统计,2019,26(3):172-174.[12]Schmidt-Ott R,Schutter U,Simon J,et al.Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: A prospective study[J].J Infect,2018,76(5):475-482.[13]卢锦钊,陈志礼,余威.基于Nomogram预测模型构建带状疱疹患者发生后遗神经痛的危险因素[J].湖南师范大学学报(医学版),2022,19(5):85-90.[14]陈燕,丁小洁,陈星,等.老年带状疱疹后遗神经痛的发病因素分析及预防[J].老年医学与保健,2018,24(5):494-496.[15]李玉秋,徐文英,潘南楠,等.带状疱疹后遗神经痛的危险因素分析[J].中国医药,2019,14(9):1406-1410.[16]Drago F,Herzum A,Ciccarese G,et al.Acute pain and postherpetic neuralgia related to Varicella zoster virus reactivation: Comparison between typical herpes zoster and zoster sine herpete[J].J Med Virol,2019,91(2):287-295.[17]赵喜燕,李虎羽.91例带状疱疹后遗神经痛发病相关因素分析[J].上海医药,2018,39(7):53-55,80.[18]陆谛,薛朝霞,余欢,等.难治性带状疱疹后神经痛危险因素分析[J].安徽医药,2021,25(8):1596-1600.[19]张丽君,毕晓东,徐全晓.带状疱疹后神经痛危险因素及GCH1基因多态性[J].中华医院感染学杂志,2021,31(6):871-875.[20]孟丹,林维茹,刘国艳.带状疱疹后遗神经痛相关危险因素分析[J].中国麻风皮肤病杂志,2020,36(3):147-150.[21]思远,李璟蓉,李群,等.199例带状疱疹后遗神经痛相关危险因素分析[J].中国麻风皮肤病杂志,2023,39(1):18-21.[22]郭玉娜,倪家骧,武百山,等.带状疱疹急性期患者后遗神经痛的相关因素分析[J].贵州医科大学学报,2019,44(3):346-349,355.[23]吴征元,王溢文,孙悦,等.糖尿病对带状疱疹后神经痛患者的预后影响及其危险因素研究[J].实用医学杂志,2021,37(14):1805-1810.[24]胡坚,钟灵芝,李婷婷,等.带状疱疹后神经痛发生的相关风险因素研究[J].中华医学杂志,2022,102(40):3181-3185.[25]Kowalsky DS,Wolfson AB.Antiviral Medications for the Prevention of Postherpetic Neuralgia After Herpes Zoster Infection[J].Acad Emerg Med,2019,26(6):684-685.